Rede D'Or São Luiz S.A (RDOR3) Fair Value & Analysis
Healthcare · BR · Market cap R$78.5B
Fair value as of: Jul 16, 2026
From 17 valuation models · updated 22 days ago
Fair value updated Jul 16, 2026, revised from R$46.90 to R$47.31 (+0.9%) since Jun 24, 2026. Share price −2.2% over the past month.
A solid business, screening 39% undervalued on our models.
What matters now
- The price is below even our cautious bear case (R$35.48). The market is more pessimistic than our downside scenario.
- Solid quality (50/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range R$17.21 – R$63.66 · fair‑value band R$35.48 – R$59.14 · the R$34.06 price screens below the R$47.31 fair value. Dashed = 300-day average. As of Jul 16, 2026.
Analysis
Rede D'Or São Luiz S.A (RDOR3) currently trades at R$34.06, while our model-based Fair Value estimate is R$47.31, implying the stock looks roughly 38.9% undervalued today. We read business quality at 50/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Rede D'Or São Luiz S.A generated revenue of R$57.1B at a net margin of 8.1%. Revenue grew 10.6% year over year. It earns a return on equity of 19.2%. Net debt stands at R$49.2B. Fundamentals as of Jul 16, 2026
Our scenario range runs from R$35.48 (bear case) to R$59.14 (bull case); at R$34.06, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 25% below its 52-week high and 18% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -12% fair-value upside, at 39%, RDOR3 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 17 models by family
Widest divergence: DCF Models (R$77.69) versus Asset-Based (R$5.95). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 48
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Rede D'Or São Luiz S.A. engages in the provision of hospital services in Brazil. The company provides assistance and hospitality concept services; and supplementary services, such as blood bank, dialysis, and outpatient clinics with various specialties.
Full company description
Rede D'Or São Luiz S.A. engages in the provision of hospital services in Brazil. The company provides assistance and hospitality concept services; and supplementary services, such as blood bank, dialysis, and outpatient clinics with various specialties. It also offers health insurance and plan, as well as dental plans for small, medium, and large-sized companies; individual plans; individual and group life, travel, credit life, endowment, as well as personal, individual, and group accident insurance products; and pension risk. In addition, the company owns and operates hospitals, and oncology and radiotherapy clinics and laboratories. Further, it is involved in asset management activities. The company was formerly known as Hospital Maternidade São Luiz S.A. Rede D'Or São Luiz S.A. was founded in 1977 and is headquartered in São Paulo, Brazil.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Rede D'Or São Luiz S.A reported revenue of R$55.7B in FY2025 versus R$20.4B in FY2021, a compound +28.6%/yr. Reported net income was R$4.7B in FY2025, compounding +31.3%/yr from FY2021.
Watch RDOR3: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,103 | ₹284.87 | -74% |
Compare Rede D'Or São Luiz S.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Rede D'Or São Luiz S.A (RDOR3) overvalued or undervalued?
What is the fair value of RDOR3?
What is the quality score of RDOR3?
What is the revenue of Rede D'Or São Luiz S.A (RDOR3)?
What is the net profit margin of RDOR3?
Does Rede D'Or São Luiz S.A pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Rede D'Or São Luiz S.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.